QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists-Reference-Cited by-同舟云学术

QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists

Published:2003-06-20 Issue:15 Volume:46 Page:3210-3220
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Austin Rupert P.¹,Barton Patrick¹,Bonnert Roger V.¹,Brown Roger C.¹,Cage Peter A.¹,Cheshire David R.¹,Davis Andrew M.¹,Dougall Iain G.¹,Ince Francis¹,Pairaudeau Garry¹,Young Alan¹

Affiliation:

1. AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm020886c

Reference35 articles.

1. Sibbald, B.; Genetics. InAsthma Basic Mechanisms and ClinicalManagement; Barnes, P. J., Rodger, I. W., Thomson, N. C., Eds.; Academic Press: London, 1992; pp 21−31. Du Toit, J.; Woolcock, A. J.; Salome, C. M. Characteristics of Broncial Hyperreactivity in Smokers with Chronic Airflow Limitation.Am. Rev. Respir. Dis.1986,134, 498−501.

2. Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)- 4-hydroxybenzothiazol-2(3H)-one Analogues

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. I₂‐Promoted [3+2] Cyclization of Thiocarbamates with Enaminones: a Protocol for the Synthesis of Polysubstituted Thiazol‐2(3H)‐ones;Advanced Synthesis & Catalysis;2024-02-21

2. Cryo-EM reveals an unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors;eLife;2023-03-28

3. Physicochemical Properties;The Handbook of Medicinal Chemistry;2023-02-03

4. Photo-induced spirocyclization of biaryl ynones with ammonium thiocyanate: access to thiocyanate-featured spiro[5,5]trienones;Green Chemistry;2023

5. CryoEM reveals unprecedented binding site for Na_V1.7 inhibitors enabling rational design of potent hybrid inhibitors;2022-11-10